Compounds > n-(3-(aminomethyl)benzyl)acetamidine
Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Intraocular Pressure

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Intraocular Pressure in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Intraocular Pressure: The pressure of the fluids in the eye.

Research Excerpts

ExcerptRelevanceReference
"4 mg) caused no significant toxic ocular effects in rabbit eyes."1.46TOWARDS A TREATMENT FOR DIABETIC RETINOPATHY: Intravitreal Toxicity and Preclinical Safety Evaluation of Inducible Nitric Oxide Synthase Inhibitors. ( Bennett, LD; Birch, DG; Carr, BC; Emigh, CE; Nguyen, C; Pansick, AD, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carr, BC1
Emigh, CE1
Bennett, LD1
Pansick, AD1
Birch, DG1
Nguyen, C1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Intraocular Pressure

ArticleYear
TOWARDS A TREATMENT FOR DIABETIC RETINOPATHY: Intravitreal Toxicity and Preclinical Safety Evaluation of Inducible Nitric Oxide Synthase Inhibitors.
    Retina (Philadelphia, Pa.), 2017, Volume: 37, Issue:1

    Topics: Amidines; Animals; Aqueous Humor; Benzylamines; Diabetic Retinopathy; Disease Models, Animal; Electr

2017